LBO — GOOD SAMARITAN MEDICAL CENTER
IRR: 19.1% | MOIC: 2.40x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.1%
IRR
2.40x
MOIC
$228.5M
Entry EV
$379.3M
Exit EV
$117.6M
Equity Invested
Sources & Uses
S&UTotal · $228.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $88.7M | 38.8% | |
| Sub Debt | $22.2M | 9.7% | |
| Equity | $117.6M | 51.5% | |
| Enterprise Value | $221.9M | 97.1% | |
| Transaction Fees | $6.7M | 2.9% | |
| Total Uses | $228.5M | 100.0% |
Interpretation
INTAt 2.40x MOIC and 19.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $36.1M |
| Exit Ev | $379.3M |
| Net Debt At Exit | $97.4M |
| Equity At Exit | $281.9M |
| Equity Invested | $117.6M |
| Total Value Created | $164.3M |
| Value From Growth | $146.3M |
| Value From Multiple | $11.1M |
| Value From Deleveraging | $13.5M |